Does Intravenous Lactated Ringer Solution Raise Measured Serum Lactate?
Sponsor: University Medical Center of Southern Nevada
A EARLY_PHASE1 clinical study on Hyperlactatemia, this trial is completed. The trial is conducted by University Medical Center of Southern Nevada and has accumulated 10 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Jan 2023 — Jul 2024 [monthly]
Completed EARLY_PHASE1
-
Dec 2022 — Jan 2023 [monthly]
Completed EARLY_PHASE1
-
Jan 2021 — Dec 2022 [monthly]
Completed EARLY_PHASE1
▶ Show 5 earlier versions
-
May 2019 — Jan 2021 [monthly]
Completed EARLY_PHASE1
-
Jun 2018 — May 2019 [monthly]
Completed EARLY_PHASE1
-
Jul 2017 — Jun 2018 [monthly]
Completed EARLY_PHASE1
Status: Not Yet Recruiting → Completed
-
Feb 2017 — Jul 2017 [monthly]
Not Yet Recruiting EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting Phase 0
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Medical Center of Southern Nevada
For direct contact, visit the study record on ClinicalTrials.gov .